Home > Healthcare > Medical Devices > Diagnostic Devices > Legionella Testing Market

Legionella Testing Market Size

  • Report ID: GMI8361
  • Published Date: Mar 2024
  • Report Format: PDF

Legionella Testing Market Size

Legionella Testing Market size was valued at around USD 316.8 million in 2023 and is anticipated to register a CAGR of around 8.6% between 2024 and 2032. Legionella testing refers to the process of detecting and identifying legionella bacteria in various environments, including water systems, clinical specimens, and other potential sources of contamination.

 

The increasing prevalence of pneumonia and legionella-related illnesses has become a major public health concern worldwide. Legionella bacteria, especially Legionella pneumophila, can cause severe respiratory infections such as Legionnaires' disease and Pontiac fever. For instance, as per the World Health Organization (WHO), in Europe, Australia, and the U.S., an estimated 10–15 cases are detected per million population each year. Among these reported cases, individuals over 50 years old account for 75–80%, while males make up 60–70% of the affected population.

 

Furthermore, governments and regulatory bodies around the world have implemented stringent regulations and guidelines for regular water testing, especially in high-risk environments such as healthcare facilities, hotels, nursing homes, and industrial settings. These regulations mandate the implementation of comprehensive water management plans, including routine legionella testing, to mitigate the risk of legionella contamination and protect public health.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global legionella testing industry was valued at USD 316.8 million in 2023 and is estimated to reach over USD 659.4 million by 2032 attributed to the increasing prevalence of pneumonia and legionella-related illnesses.

Water legionella testing industry accounted for USD 193.6 million in 2023 and will grow significantly through 2032 attributed to the heightened awareness surrounding legionella-related illnesses, such as legionnaires' disease.

North America recorded 40.6% of the legionella testing industry share in 2023 and is predicted to witness substantial growth through 2032 as the region has a robust healthcare infrastructure and regulatory framework that emphasizes the importance of legionella testing for public health and safety.

Abbott Laboratories, Becton, Dickinson & Company, Biomerieux, Bio-Rad Laboratories Inc., Danaher Corporation, IDEXX Laboratories Inc, Merck KGaA, Pro-lab Diagnostics Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc.

Legionella Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 339
  • Countries covered: 22
  • Pages: 201
 Download Free Sample